| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1093/JNCI/90.18.1335 |
| P698 | PubMed publication ID | 9747865 |
| P2093 | author name string | B E Johnson | |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 1335-1345 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Second lung cancers in patients after treatment for an initial lung cancer | |
| P478 | volume | 90 |
| Q40271942 | 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial. |
| Q91899486 | A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers |
| Q87949870 | Adjuvant vinorelbine and cisplatin after complete resection of stage II and III non-small cell lung cancer: long-term follow-up of our study of Japanese patients |
| Q33759593 | Attentional and executive dysfunction as predictors of smoking within the Childhood Cancer Survivor Study cohort |
| Q36303234 | Bronchial sleeve resection for early-stage squamous cell carcinoma |
| Q30720361 | Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up study. |
| Q21285045 | Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin |
| Q48242111 | Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database |
| Q83616295 | Chemoprevention of lung cancer |
| Q37111529 | Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines |
| Q28386632 | Chemoprevention of lung cancer: prospects and disappointments in human clinical trials |
| Q53065388 | Clinical features of multiple lung cancers based on thin-section computed tomography: what are the appropriate surgical strategies for second lung cancers? |
| Q37562236 | Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma |
| Q80529481 | Clonal divergence in lung cancer development is associated with allelic loss on chromosome 4 |
| Q36463109 | Comprehensive long-term care of patients with lung cancer: development of a novel thoracic survivorship program |
| Q35996056 | Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer |
| Q36183327 | Correlates of continued smoking versus cessation among survivors of smoking-related cancers |
| Q64911262 | Diagnosis and treatment of synchronous multiple primary lung cancer - a case report. |
| Q49455240 | Different histological types of triple metachronous primary lung carcinomas in 1 patient: Case report |
| Q34747242 | Does the method of radiologic surveillance affect survival after resection of stage I non-small cell lung cancer? |
| Q50724707 | Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. |
| Q64227379 | Efficacy of carboplatin plus S-1 for the treatment of non-small cell lung cancer: A protocol for a systematic review of randomized controlled trial |
| Q24600475 | Epidemiology of lung cancer |
| Q34135295 | Epidemiology of lung cancer prognosis: quantity and quality of life |
| Q34419269 | Fluorescence bronchoscopy for early detection of lung cancer: a clinical perspective |
| Q35894705 | Fluorescent bronchoscopy |
| Q34677893 | Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection |
| Q36597905 | Harm reduction and cessation efforts and interest in cessation resources among survivors of smoking-related cancers |
| Q44206435 | Health perceptions and risk behaviors of lung cancer survivors |
| Q88765488 | Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival |
| Q60301748 | Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors |
| Q37942070 | Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria |
| Q74518403 | Late events and clinical prognostic factors in stage I non small cell lung cancer |
| Q50862063 | Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial. |
| Q92004132 | Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of Study |
| Q84053354 | Lung cancer chemoprevention |
| Q26995495 | Lung cancer chemoprevention: current status and future prospects |
| Q47121935 | Lung reirradiation with stereotactic body radiotherapy (SBRT). |
| Q34569398 | Management of small cell lung cancer |
| Q35948081 | Metachronous second primary lung cancer surgically treated five years or more after the initial surgery |
| Q35663591 | Multiple primary cancers involving lung cancer at a single tertiary hospital: Clinical features and prognosis |
| Q38835727 | Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk? |
| Q93377901 | Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation |
| Q47401261 | Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? |
| Q38232404 | Optical spectroscopy and imaging for early lung cancer detection: a review. |
| Q36648979 | Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years |
| Q33414030 | Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels |
| Q40717228 | Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients. |
| Q36180316 | Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population |
| Q35150980 | Prevention of bronchial hyperplasia by EGFR pathway inhibitors in an organotypic culture model |
| Q42764703 | Previous tumour as a predictor of risk of developing lung cancer |
| Q36225638 | Previous tumour as a prognostic factor in stage I non-small cell lung cancer |
| Q36753846 | Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. |
| Q92059115 | Radiotherapy was associated with the lower incidence of metachronous second primary lung cancer |
| Q33561943 | Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. |
| Q34977797 | Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. |
| Q73459814 | Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas |
| Q36153723 | Repeated occurrence of second primary lung cancer at different sites in trachea: a case report |
| Q38711992 | Risk Stratification for Second Primary Lung Cancer |
| Q47842076 | Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data |
| Q48038572 | Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different Treatments. |
| Q36493928 | SBRT Treatment of Metachronous Small-Cell and Non-Small-Cell Lung Carcinomas in a Patient with Severe COPD. |
| Q43994923 | Second primary cancers in patients with lung carcinoma |
| Q47602832 | Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer |
| Q60021974 | Small cell lung cancer |
| Q34130705 | Smoking cessation: an integral part of lung cancer treatment |
| Q85680920 | Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis |
| Q36550532 | Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicity |
| Q36105945 | Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation |
| Q36555959 | Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. |
| Q36324363 | Successes and failures of the teachable moment: smoking cessation in cancer patients |
| Q34195653 | Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma |
| Q88178902 | Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact? |
| Q58791524 | Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study |
| Q33745383 | Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward |
| Q34047827 | Techniques of endoscopic airway tumor treatment |
| Q33679559 | The Effects of smoking status and smoking history on patients with brain metastases from lung cancer. |
| Q54960538 | The risk of second primary lung cancer: an unsolved dilemma. |
| Q44608744 | The risk of second primary tumors after resection of stage I nonsmall cell lung cancer |
| Q34461768 | The role of photodynamic therapy in the management of stage I/II NSCLC. |
| Q37735284 | Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment |
| Q55002557 | Thoracoscopic wedge resection in single-lung patients. |
| Q36915220 | Time course of risk factors in cancer etiology and progression |
| Q37346863 | Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers |
| Q43939698 | Treatment update in small-cell lung cancer: from limited to extensive disease |
| Q41585447 | Triple synchronous primary lung cancer: a case report and review of the literature |
| Q97537630 | Unexpected encounters: high prevalence of synchronous primary lung cancers in a tertiary academic center |
| Q50721606 | Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: Preliminary report. |
| Q81072386 | [Imaging and PET/CT of lung cancer] |
Search more.